Filter Characteristics Influencing Circulating Tumor Cell Enrichment from Whole Blood

A variety of filters assays have been described to enrich circulating tumor cells (CTC) based on differences in physical characteristics of blood cells and CTC. In this study we evaluate different filter types to derive the properties of the ideal filter for CTC enrichment. Between 0.1 and 10 mL of whole blood spiked with cells from tumor cell lines were passed through silicon nitride microsieves, polymer track-etched filters and metal TEM grids with various pore sizes. The recovery and size of 9 different culture cell lines was determined and compared to the size of EpCAM+CK+CD45−DNA+ CTC from patients with metastatic breast, colorectal and prostate cancer. The 8 µm track-etched filter and the 5 µm microsieve had the best performance on MDA-231, PC3-9 and SKBR-3 cells, enriching >80% of cells from whole blood. TEM grids had poor recovery of ∼25%. Median diameter of cell lines ranged from 10.9–19.0 µm, compared to 13.1, 10.7, and 11.0 µm for breast, prostate and colorectal CTC, respectively. The 11.4 µm COLO-320 cell line had the lowest recovery of 17%. The ideal filter for CTC enrichment is constructed of a stiff, flat material, is inert to blood cells, has at least 100,000 regularly spaced 5 µm pores for 1 ml of blood with a ≤10% porosity. While cell size is an important factor in determining recovery, other factors must be involved as well. To evaluate a filtration procedure, cell lines with a median size of 11–13 µm should be used to challenge the system.

[1]  Peter Kuhn,et al.  High speed detection of circulating tumor cells. , 2006, Biosensors & bioelectronics.

[2]  J R Siewert,et al.  Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. , 2002, Cytometry.

[3]  W. Shyy,et al.  Effects of Nucleus on Leukocyte Recovery , 1999, Annals of Biomedical Engineering.

[4]  O. Makarova,et al.  Abstract 2369: Isolation of circulating tumor cells by size exclusion using lithography fabricated precision microfilters , 2011 .

[5]  M. Campone,et al.  Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  M. Campone,et al.  High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Mark M Davis,et al.  Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device , 2009, Proceedings of the National Academy of Sciences.

[8]  Bo Lu,et al.  3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood , 2011, Biomedical microdevices.

[9]  Bo Lu,et al.  A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. , 2010, Cancer research.

[10]  Leon W M M Terstappen,et al.  Statistical considerations for enumeration of circulating tumor cells , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[11]  S. Groshen,et al.  Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells , 2010, Clinical Cancer Research.

[12]  L. Lagae,et al.  Automated genotyping of circulating tumor cells , 2010, Expert review of molecular diagnostics.

[13]  Leon W. M. M. Terstappen,et al.  Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival , 2011, PloS one.

[14]  H. Groen,et al.  Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  Chwee Teck Lim,et al.  Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. , 2010, Biosensors & bioelectronics.

[16]  Markus Beck,et al.  Filtration Parameters Influencing Circulating Tumor Cell Enrichment from Whole Blood , 2013, PloS one.

[17]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.

[18]  T. Molina,et al.  Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. , 2011, American journal of clinical pathology.

[19]  J. Chalmers,et al.  Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells. , 2009, Molecular pharmaceutics.

[20]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[21]  H. Zuilhof,et al.  Stable protein-repellent zwitterionic polymer brushes grafted from silicon nitride. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[22]  Caroline Dive,et al.  Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[24]  I. Nagtegaal,et al.  Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  K. Chìn,et al.  Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer , 2010, Cancer science.

[26]  P. Kober,et al.  The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes. , 2006, European journal of cancer.

[27]  T. Maudelonde,et al.  Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients. , 2005, Clinical chemistry.

[28]  Yi-Kuen Lee,et al.  Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. , 2011, Angewandte Chemie.

[29]  T. Kroll,et al.  Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Chwee Teck Lim,et al.  Modeling cell entry into a micro-channel , 2011, Biomechanics and modeling in mechanobiology.

[31]  M. Middleton,et al.  Circulating melanoma cells and survival in metastatic melanoma. , 2011, International journal of oncology.

[32]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[33]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[34]  P. Nibbering,et al.  Mean cell volume of human blood leucocytes and resident and activated murine macrophages. , 1990, Journal of immunological methods.

[35]  J. Uhr,et al.  Challenges in the Enumeration and Phenotyping of CTC , 2012, Clinical Cancer Research.

[36]  M C Miller,et al.  Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Jaap den Toonder,et al.  Circulating tumor cells: the Grand Challenge. , 2011, Lab on a chip.

[38]  C. Lim,et al.  Deformability study of breast cancer cells using microfluidics , 2009, Biomedical microdevices.

[39]  J. Bono,et al.  All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  Jason P. Gleghorn,et al.  Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. , 2010, Lab on a chip.

[41]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[42]  Francis Barany,et al.  High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system. , 2011, Analytical chemistry.